<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-28450497.post2223682920467862220..comments</id><updated>2009-04-02T11:04:56.480-04:00</updated><category term='Channel Management'/><category term='Supply Chain Technology'/><category term='Blog Administration'/><category term='Importation'/><category term='Health Care Policy'/><category term='Group Purchasing Organizations (GPOs)'/><category term='Drug Shortages'/><category term='Industry Trends'/><category term='Fun Stuff'/><category term='PBMs'/><category term='Wholesalers'/><category term='Pharmacy Economics'/><category term='Pharmacy'/><category term='Supply Chain Humor'/><category term='Drug Counterfeiting'/><category term='Health Care Reform'/><category term='Pharmacogenomics'/><category term='Pedigree'/><category term='Specialty Drugs'/><category term='Medicare Part D'/><category term='Average Sales Price (ASP)'/><category term='Accountable Care Organizations (ACOs)'/><category term='Generic Drugs'/><category term='Guest Post'/><category term='Marketing'/><category term='RFID'/><category term='Average Acquisition Cost (AAC)'/><category term='International Drug Channels'/><category term='Enforcement'/><category term='Costs/Reimbursement'/><category term='Average Manufacturer Price (AMP)'/><category term='Mergers and Acquisitions'/><title type='text'>Comments on Drug Channels: CVS Caremark's "Insignificant Impact"</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://www.drugchannels.net/feeds/2223682920467862220/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/2223682920467862220/comments/default'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/04/cvs-caremarks-insignificant-impact.html'/><author><name>Adam J. Fein, Ph.D.</name><uri>http://www.blogger.com/profile/12217252282643255442</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='25' height='32' src='http://4.bp.blogspot.com/_jauTfEtde80/TTnq9WCPzYI/AAAAAAAAAAM/VNKwcn8y_BA/s220/AdamJFein-DrugChannels.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>2</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-28450497.post-5474196951885988743</id><published>2009-04-02T10:53:00.000-04:00</published><updated>2009-04-02T10:53:00.000-04:00</updated><title type='text'>This is interesting and should be a wake up call t...</title><content type='html'>This is interesting and should be a wake up call to many.  I've talked to a number of people that have raised concerns about the size of this giant.  We've not seen the industry take advantage of these types of mergers in the past.  That is not to say CVS Caremark can't/won't but the reality is that to make the biggest splash would mean big changes for both and that is tough on cultures of both companies.&lt;BR/&gt;&lt;BR/&gt;I'd be more concerned about other changes in the market, namely WalMart (even before the aquisition of Walgreens :)) and their pursuit of business that makes sense for their model.  Not to mention the impact that mega-mergers have on wholesalers and the resulting ripples from those impacts.&lt;BR/&gt;&lt;BR/&gt;Al Godley</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/2223682920467862220/comments/default/5474196951885988743'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/2223682920467862220/comments/default/5474196951885988743'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/04/cvs-caremarks-insignificant-impact.html?showComment=1238683980000#c5474196951885988743' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/04/cvs-caremarks-insignificant-impact.html' ref='tag:blogger.com,1999:blog-28450497.post-2223682920467862220' source='http://www.blogger.com/feeds/28450497/posts/default/2223682920467862220' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-225690012'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-8059647332042115068</id><published>2009-04-02T09:36:00.000-04:00</published><updated>2009-04-02T09:36:00.000-04:00</updated><title type='text'>While Wall Street may have not noticed, community ...</title><content type='html'>While Wall Street may have not noticed, community pharmacy has. More and more of our commercial insurance (not medicaid/medicare)customers are being directed to CVS retail stores by mailings from CVS Caremark. If CVS cannot create "significant" impact from their shooting fish in a barrel strategy, shame on them and their corporate leaders. I wish I had such a built in advantage for our two pharmacies</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/2223682920467862220/comments/default/8059647332042115068'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/2223682920467862220/comments/default/8059647332042115068'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/04/cvs-caremarks-insignificant-impact.html?showComment=1238679360000#c8059647332042115068' title=''/><author><name>erich</name><uri>http://www.blogger.com/profile/02094210452909700014</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/04/cvs-caremarks-insignificant-impact.html' ref='tag:blogger.com,1999:blog-28450497.post-2223682920467862220' source='http://www.blogger.com/feeds/28450497/posts/default/2223682920467862220' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-476549409'/></entry></feed>
